SKIN Cash-Secured Put Strategy

SKIN (SkinHealth Systems Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.

SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.

SKIN (SkinHealth Systems Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $83.8M, a beta of 1.07 versus the broader market, a 52-week range of 0.551-2.69, average daily share volume of 2.1M, a public-listing history dating back to 2020, approximately 613 full-time employees. These structural characteristics shape how SKIN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 1.07 places SKIN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a cash-secured put on SKIN?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

SKIN snapshot

As of August 14, 2026, spot at $0.67, ATM IV 86.40%, IV rank 25.09%, expected move 24.77%. The cash-secured put on SKIN below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this cash-secured put structure on SKIN specifically: SKIN IV at 86.40% is on the cheap side of its 1-year range, which means a premium-selling SKIN cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 24.77% (roughly $0.17 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SKIN expiries trade a higher absolute premium for lower per-day decay. Position sizing on SKIN should anchor to the underlying notional of $0.67 per share and to the trader's directional view on SKIN stock.

SKIN cash-secured put setup

The SKIN cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SKIN at $0.67 on that close, the first option leg uses a $0.64 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SKIN chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SKIN shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$0.64N/A

SKIN cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

SKIN cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on SKIN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on SKIN

Cash-secured puts on SKIN earn premium while a trader waits to acquire SKIN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning SKIN.

SKIN thesis for this cash-secured put

The market-implied 1-standard-deviation range for SKIN extends from approximately $0.50 on the downside to $0.84 on the upside. A SKIN cash-secured put lets a trader earn premium while waiting to acquire SKIN at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current SKIN IV rank near 25.09% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on SKIN at 86.40%. As a Healthcare name, SKIN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SKIN-specific events.

SKIN cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SKIN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SKIN alongside the broader basket even when SKIN-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on SKIN carry tail risk when realized volatility exceeds the implied move; review historical SKIN earnings reactions and macro stress periods before sizing. Always rebuild the position from current SKIN chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on SKIN?
A cash-secured put on SKIN is the cash-secured put strategy applied to SKIN (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With SKIN stock at $0.67 on the most recent close, the strikes shown on this page are snapped to the nearest listed SKIN chain strike and the premiums come straight from that session's bid/ask midpoint.
How are SKIN cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the SKIN cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 86.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a SKIN cash-secured put?
The breakeven for the SKIN cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The SKIN market-implied 1-standard-deviation expected move in the same options snapshot is approximately 24.77%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on SKIN?
Cash-secured puts on SKIN earn premium while a trader waits to acquire SKIN stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning SKIN.
How does current SKIN implied volatility affect this cash-secured put?
SKIN ATM IV is at 86.40% with IV rank near 25.09%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related SKIN analysis